|
Name |
8-(2-methylbutyryl)-neosolaniol
|
Molecular Formula | C26H38O7 | |
IUPAC Name* |
[10-hydroxy-1,5-dimethyl-4-(3-methyl-2-oxopentyl)-2-(3-oxobutyl)spiro[8-oxatricyclo[7.2.1.02,7]dodec-5-ene-12,2'-oxirane]-11-yl]acetate
|
|
SMILES |
CCC(C)C(=O)CC1CC2(CCC(C)=O)C(C=C1C)OC1C(O)C(OC(C)=O)C2(C)C12CO2
|
|
InChI |
InChI=1S/C26H38O7/c1-7-14(2)19(29)11-18-12-25(9-8-16(4)27)20(10-15(18)3)33-23-21(30)22(32-17(5)28)24(25,6)26(23)13-31-26/h10,14,18,20-23,30H,7-9,11-13H2,1-6H3/t14?,18-,20+,21+,22+,23+,24+,25-,26-/m0/s1
|
|
InChIKey |
ZNHTVPBUKPIKDE-YRIVAKJFSA-N
|
|
Synonyms |
NA
|
|
CAS | NA | |
PubChem CID | NA | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 462.58 | ALogp: | 3.2 |
HBD: | 1 | HBA: | 7 |
Rotatable Bonds: | 8 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 102.4 | Aromatic Rings: | 4 |
Heavy Atoms: | 33 | QED Weighted: | 0.331 |
Caco-2 Permeability: | -4.972 | MDCK Permeability: | 0.00001670 |
Pgp-inhibitor: | 0.751 | Pgp-substrate: | 0.993 |
Human Intestinal Absorption (HIA): | 0.38 | 20% Bioavailability (F20%): | 0.065 |
30% Bioavailability (F30%): | 0.924 |
Blood-Brain-Barrier Penetration (BBB): | 0.762 | Plasma Protein Binding (PPB): | 84.81% |
Volume Distribution (VD): | 1.041 | Fu: | 18.32% |
CYP1A2-inhibitor: | 0.007 | CYP1A2-substrate: | 0.289 |
CYP2C19-inhibitor: | 0.025 | CYP2C19-substrate: | 0.905 |
CYP2C9-inhibitor: | 0.04 | CYP2C9-substrate: | 0.085 |
CYP2D6-inhibitor: | 0.006 | CYP2D6-substrate: | 0.383 |
CYP3A4-inhibitor: | 0.463 | CYP3A4-substrate: | 0.594 |
Clearance (CL): | 15.013 | Half-life (T1/2): | 0.263 |
hERG Blockers: | 0.006 | Human Hepatotoxicity (H-HT): | 0.57 |
Drug-inuced Liver Injury (DILI): | 0.322 | AMES Toxicity: | 0.039 |
Rat Oral Acute Toxicity: | 0.968 | Maximum Recommended Daily Dose: | 0.054 |
Skin Sensitization: | 0.018 | Carcinogencity: | 0.371 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.009 |
Respiratory Toxicity: | 0.054 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC005517 | 0.644 | D0H2MO | 0.253 | ||||
ENC005516 | 0.642 | D0X7XG | 0.247 | ||||
ENC003580 | 0.609 | D01ZOG | 0.242 | ||||
ENC003104 | 0.602 | D0L2UN | 0.241 | ||||
ENC001179 | 0.600 | D0G7KJ | 0.240 | ||||
ENC005587 | 0.600 | D0X2LV | 0.237 | ||||
ENC003278 | 0.598 | D06WTZ | 0.235 | ||||
ENC002259 | 0.585 | D02RQU | 0.234 | ||||
ENC003086 | 0.569 | D0E9KA | 0.232 | ||||
ENC003277 | 0.306 | D09WYX | 0.231 |